Skip to main content
. 2020 Dec 17;12(12):3867. doi: 10.3390/nu12123867

Figure 7.

Figure 7

Baicalein and myricetin battled against ODC-evoked cellular anti-apoptosis. (A,D) Fold change in growth of HL-60 cells with ODC-empty vector (ODC-empty) and ODC-overexpressing vector (ODC-WT) in the absence or presence of 50 µM baicalein or 75 µM myricetin, respectively. * p < 0.01, *** p < 0.001 (n = 3). (B,E) Apoptotic bodies in the ODC-empty and ODC-WT HL-60 cells (indicated by arrows) were present after treatment with 50 µM baicalein and 75 µM myricetin, respectively. (C,F) DNA fragmentation in the ODC-empty and ODC-WT HL-60 cells (indicated by arrows) was present after treatment with 50 µM baicalein and 75 µM myricetin, respectively.